Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2024 Oct 31;19(10):e0308406. doi: 10.1371/journal.pone.0308406

Assessment of knowledge and perception of prescribers towards rational medicine use in the Ashanti Region of Ghana

Richard Delali Agbeko Djochie 1,*,#, Rita Owusu-Donkor 2,#, Elizabeth Modupe d’Almeida 3,#, Francis Kwadwo Gyamfi Akwah 4,, Emmanuel Kyeremateng 2,, Samuel Opoku-Afriyie 5,, Cecilia Akosua Tabiri 6,, Francis Kyei-Frimpong 7,, Samuel Dwomoh 2,, Jonathan Boakye-Yiadom 8,#
Editor: Obed Kwabena Offe Amponsah9
PMCID: PMC11527319  PMID: 39480833

Abstract

Background

Prescribers must possess extensive knowledge and maintain a positive attitude towards the rational use of medicines to achieve desirable treatment outcomes and effectively prevent treatment failures, increased costs, drug toxicities, and interactions. The objective of this study was to evaluate prescribers’ understanding and perception concerning the rational use of medicines in public hospitals. Additionally, the study aimed to identify the factors that influence rational prescribing practices.

Methods

A structured data instrument was developed to collect demographic data and evaluate participants’ knowledge and perception of rational medicine use, in line with the study objectives. Chi-squared statistics and Fisher’s exact test were utilized to identify factors associated with good knowledge and perception among participants. Logistic regression was then employed to assess the strength of the associations, with odd ratios reported at a significant level of 0.05.

Results

Out of 192 participants, 85.4% held a positive view of rational medicine use, stressing patient safety and recognizing risks like antimicrobial resistance and polypharmacy. Perception was influenced by factors such as prescriber profession, access to references, and drug bulletin updates. Additionally, 65.6% demonstrated good knowledge of rational medicine use, which was notably influenced by factors like using standard prescribing guidelines, having a functional Drug and Therapeutics Committee, prescriber profession, and the frequency of drug bulletin updates.

Conclusion

The study emphasizes the critical need to address knowledge gaps among healthcare professionals, especially nurses and other prescribers, to ensure the safe and effective use of medications. It highlights the positive influence of utilizing preferred prescribing references and the existence of functional Drug and Therapeutics Committees in hospitals on knowledge levels. However, the unexpected findings regarding the limited impact of frequent updates of drug bulletins require further investigation.

Introduction

Rational prescribing practices have been recognized as crucial to enhancing healthcare outcomes and decreasing healthcare expenses [1]. To achieve this goal, it is imperative for prescribers to possess extensive knowledge, along with a positive attitude and perception towards rational medication use [2, 3]. It is widely acknowledged that the excessive or improper utilization of drugs can lead to treatment failures, escalated treatment costs, drug toxicities, and drug interactions [1, 4, 5]. Although prescribing is commonly viewed as a routine task, it is a complex procedure requiring healthcare providers to possess sufficient knowledge and adhere to sound therapeutic principles. Effective communication skills and a proper understanding of risks and uncertainties are also essential [6].

The prescribing process often begins by establishing the desired therapeutic goals, such as reducing fever, eliminating an infection, or providing contraception. The goals may be influenced by patient expectations and preferences. Once the goals are determined, a suitable treatment is chosen, which can be challenging due to the various available options [7]. Ideally, the final selection of medication should be made after conducting a comprehensive benefit—risk analysis, considering both the medical factors and the patient’s circumstances, including availability and cost [6, 8, 9]. Patient-related factors, such as physiological conditions (e.g., allergy, liver impairment), susceptibility to adverse effects, and concurrent drug therapy, may influence the medicine selection process by potentially leading to drug interactions [9, 10]. Additionally, drug-related factors, such as safety and efficacy evidence, as well as pharmacokinetic and pharmacodynamic properties, may also play a role in the selection process. For example, a medication with a once-daily dosing schedule might be preferred over one with multiple doses to enhance patient compliance, especially in the elderly who are likely to forget and therefore miss some doses [9, 11].

Consequently, the prescriber plays a pivotal role in implementing policies for rational medicine use, ensuring patient safety. However, numerous studies have identified gaps in prescriber knowledge and perceptions regarding rational prescribing practices in low- and middle-income countries (LMICs) [1216]. For instance, in research carried out in Pakistan [17], it was reported that more than 60% of general practitioners (GPs) depend on pharmaceutical company representatives to receive updates on antihypertensive medications. Additionally, over 40% of GPs inappropriately prescribe sedatives to elderly patients [17]. Moreover, 23% of GPs mistakenly cease treatment once they have successfully achieved blood pressure control [17]. Likewise, another investigation carried out in healthcare facilities in rural Burkina Faso revealed that merely 50% of the prescribed doses of antimalarial medications were in accordance with the recommendations, while antibiotics were prescribed at approximately 200% higher than the recommended doses [18]. Consequently, this led to treatment failures in the case of antimalarials and undesired effects in the case of antibiotics [18].

Prescribing is a skill that is honed through years of practical experience, as it is rarely taught comprehensively in schools. In fact, junior doctors often lack the confidence to prescribe medications [19, 20], as it is a complex process that requires the ability to consider individual and regulatory factors to avoid suboptimal prescribing [21]. There is ample evidence demonstrating the widespread occurrence of irrational prescribing practices worldwide, particularly in developing countries [2224]. These practices encompass polypharmacy, inappropriate use of antibiotics and injections, prescribing expensive branded medications when unnecessary, and more. The consequences of such irrational prescribing practices are numerous, including patients failing to adhere to treatment due to adverse effects resulting from drug interactions, and an increase in hospitalizations due to these adverse effects [2527]. As a result of irrational prescribing, patients lose confidence in the healthcare system and may turn to unorthodox treatments when their quality of life is affected [28].

Rational medicine usage in the Ashanti Region of Ghana has witnessed notable advancements in the past five years, particularly concerning the prescription of generic medications from the essential medicines list and the promotion of safe injection practices [29]. However, healthcare authorities and policymakers continue to grapple with significant concerns surrounding inappropriate antibiotic usage and polypharmacy, which demand urgent attention [29]. Possessing a good knowledge and perception of rational prescribing equips physicians with the skills and understanding necessary to make informed decisions about medication use [30]. It enhances patient safety, improves treatment outcomes, optimizes resource utilization, supports antimicrobial stewardship, promotes patient-centred care, facilitates adherence to guidelines, and underscores professional competence [1, 3133].

There is a scarcity of research regarding the knowledge and perception of rational prescribing among physicians in Ghana. However, the prescribing of medications in Ghanaian hospitals involves various categories of healthcare professionals, including doctors, physician assistants, nurses, mental health nurses, and disease control officers, among others. These diverse prescriber groups may possess varying knowledge bases and perceptions concerning rational prescribing, and their practices can have an impact on patient safety and the emergence of antimicrobial resistance. Given the extent of inappropriate antibiotic prescriptions, the prevalence of polypharmacy, and the rising expenses associated with the preference for branded medications in the region [29], it becomes imperative for health authorities and policymakers to gain a comprehensive understanding of the knowledge level of these prescribers on rational use of medicines (RUM). Consequently, the objective of this study was to assess the knowledge and perception of prescribers in public hospitals in the Ashanti Region regarding the RUM, as well as to explore the factors associated with their understanding and practices. The findings from this study will inform what measures should be implemented to improve rational prescribing in the region to ensure patient drug safety.

Methods

Study design and sampling

This study employed a cross-sectional design and included prescribers from public primary and secondary hospitals in the region. Medication prescribing in Ghanaian hospitals involves a diverse range of healthcare professionals, comprising doctors, physician assistants, nurses, midwives, mental health nurses, community health nurses and disease control officers. Prescribers who are general nurses and midwives were categorized as “nurses” and community health nurses, mental health nurses and disease control officers were classified as “others”. While there exists a register of doctors and physician assistants, the same cannot be said for other types of prescribers. Consequently, it was challenging to determine the exact number of prescribers in public hospitals within the region. Therefore, all prescribers in the 25 public hospitals in the region were approached for participation and only those who willingly agreed to take part in the study and provided informed consent were included as participants.

Data collection and analysis

A structured questionnaire with 34 items was developed in line with the study objectives to collect demographic information from participants and evaluate their knowledge and perception of rational prescribing. The data instrument used in this study is available in the supporting information section as S1 Tool. The reliability and validity of the questionnaire were assessed to ensure the robustness of the study findings by pretesting the data collection instrument among prescribers in one district hospital. Data collection for the main study was conducted by research assistants personally delivering the questionnaires to the prescribers in their hospitals. Participants were allowed the entire day to complete the questionnaire. The completed questionnaires were then retrieved at the end of the day. Participant recruitment and data collection took place between August 10th and September 10th, 2023.

To evaluate participants’ knowledge, a selection of eleven questionnaire items (Q14—Q24) was utilized. These items encompassed understanding the distinction between generic and proprietary names, familiarity with guidelines for safe injection prescribing and nonpolypharmacy, and knowledge regarding the rational usage of antibiotics. The RUM knowledge score was calculated by summing the correct answers for questions 14 to 24, with each correct answer earning one point. The total points accrued were then converted into percentages by dividing by 11 (the maximum possible score) and multiplying by 100 and rounded to one decimal place using standard rounding rules. Respondents who achieved a score of 70% or higher were classified as having a good RUM knowledge while any score below 70% indicated poor knowledge.

The participant’s perception of RUM was assessed using a Likert scale comprising six items (items 25–30). These questions aimed to gauge participants’ attitudes and beliefs regarding various aspects of RUM, such as appropriateness of prescribing (item 25), adherence to guidelines (item 26), patient-centred care (items 27 and 29), and avoidance of polypharmacy (items 28 and 30). Responses ranged from "Strongly Disagree" to "Strongly Agree," coded as 1–5. A higher score indicated a more positive perception. A composite perception score was calculated by summing the responses to all six items. Scores of 24–30 were classified as good perception, 18–23 as neutral perception, and any score below 18 as poor perception.

Functional Drug and Therapeutic Committee (DTC) status was determined based on participants who responded affirmatively to at least three of the following questions: awareness of a DTC operating in their hospital (item 31), knowledge of a recent RUM survey conducted within the past six months in their hospital (item 32), familiarity with the findings of the RUM survey in their hospital (item 33), and participation in a RUM training or refresher course held within their hospital (item 34).

The collected data underwent cleaning using Microsoft Excel 2016 and was then imported into Stata version 17 for analysis. Microsoft Word 2016 was utilized to create charts and tables. Categorical data were reported in frequencies and percentages, with Chi-squared or Fisher’s exact test used for comparisons. Continuous data were presented as mean (SD) or median (interquartile range). Binary logistic regression (odds ratios) compared knowledge types among participant factors such as age, gender, type of hospital, and prescriber category. Ordinal logistic regression analyzed participants’ odds of transitioning from neutral to good perception. Statistical significance was set at p < 0.05.

The dataset used to analyse the knowledge and perception of prescribers towards RUM is provided as a supplementary material in the supporting information section (S1 Dataset).

Ethical consideration

Prescribers who voluntarily agreed to participate in this study provided informed consent after a comprehensive explanation of the study’s objectives. To safeguard participant confidentiality, all identifying information was deliberately excluded during the data collection process. Prescribers were granted ample privacy and flexibility to respond to the questionnaire, with the entire day available for submission. This study protocol received ethical approval from the ethics committee at Kwame Nkrumah University of Science and Technology and was issued a certificate bearing the number CHRPE/AP/706/23 on 8th August 2023.

Results

Sociodemographic characteristics of participants

Out of the 215 questionnaires that were distributed, 192 were completed and returned, resulting in a response rate of 89.3%. The participant demographics are presented in Table 1, revealing that the majority of participants were male (53.1%), married (54.8%), and identified as physician assistants (29.2%). Additionally, 90.6% of the participants worked in primary-level hospitals. The mean age of the participants was 34.4 years (±7.7). Half of the respondents had been working as prescribers for 3 years or less, while 32.1% had been in their current hospital positions for over six years.

Table 1. Socio-demographic characteristics of study participants.

Characteristic Number of respondents n (%)
Age
20–25 21 (11.9)
26–35 90 (50.8)
36–45 53 (29.9)
46–55 13 (7.4)
Gender
Male 102 (53.1)
Female 90 (46.9)
Marital status
Married 107 (55.7)
Single 83 (43.3)
Widowed 2 (1.0)
Level of hospital of practice
Primary 174 (90.6)
Secondary 18 (9.4)
Category of prescriber
Medical Officer 47 (24.5)
Medical Intern 7 (3.7)
Physician Assistant 56 (29.2)
Physician Assistant Intern 30 (15.6)
Nurse Prescriber 36 (18.8)
Others 16 (8.2)
Employment status
Permanent 146 (76.6)
Temporal (locum) 8 (4.2)
Trainee 35 (19.2)
Years of practice
≤3 years 96 (50.0)
>3–6 years 34 (17.7)
>6–10 years 37 (19.3)
>10 years 25 (13.0)

Participants’ perception of rational use of medicines

The majority of participants demonstrated a good perception of rational medicine use, with 85.4% (n = 164) having a positive perception. Most of them prioritize patient safety over simply curing diseases, with 82.2% agreeing. Additionally, 80.7% agree that irrational prescribing contributes to antimicrobial resistance. Most respondents (81.7%) believe injections aren’t inherently more effective than other forms of medication. Concerns about polypharmacy’s risk of drug interactions are shared by 75.0% of respondents. Furthermore, 64.5% agree that irrational prescribing can lead to hospitalizations, while 86.9% support reserving certain medicines for specialist prescribing. Factors significantly associated with perception of rational medicine use included prescriber profession (p = 0.011), availability of reference sources (p = 0.026), frequency of drug bulletin updates (p = 0.007), and the use of Medscape as a reference (p = 0.046) (Table 2). These associations were further analyzed using ordinal regression.

Table 2. Comparison of participant characteristics with knowledge and perception of rational medicine use.

Characteristic RUM Knowledge RUM Perception
Good n (%) Poor n (%) *p-value Good n (%) Neutral n (%) Poor n (%) δp-value
Drug bulletin as reference 0.174 0.169
Yes 99 (68.3) 46 (31.7) 125 (86.5) 10 (6.9) 10 (6.9)
No 27 (57.5) 20 (42.6) 39 (83.0) 7 (14.9) 1 (2.1)
STG as reference 0.001 0.315
Yes 100 (72.5) 38 (27.5) 121 (87.7) 10 (7.2) 7 (5.1)
No 26 (48.2) 28 (51.9) 43 (79.6) 7 (13.0) 4 (7.4)
BNF as reference 0.001 0.609
Yes 67 (77.9) 19 (22.1) 74 (86.0) 6 (7.0) 6 (7.0)
No 59 (55.7) 47 (44.3) 90 (84.9) 11 (10.4) 5 (4.7)
Medscape as reference 0.057 0.046
Yes 58 (73.4) 21 (26.6) 66 (83.5) 11 (13.9) 2 (2.5)
No 68 (60.2) 45 (39.8) 98 (86.7) 6 (5.3) 9 (8.0)
Reference source accessible 0.323 0.026
Yes 89 (67.9) 42 (32.1) 118 (90.1) 8 (6.1) 5 (3.8)
No 37 (60.7) 24 (39.3) 46 (75.4) 9 (14.8) 6 (9.8)
Drug bulletin updates 0.001 0.007
Never 35 (64.8) 19 (35.2) 48 (88.9) 5 (9.3) 1 (1.9)
Quarterly 45 (69.2) 20 (30.8) 60 (92.3) 2 (3.1) 3 (4.6)
Monthly 34 (82.9) 7 (17.1) 36 (87.8) 3 (7.3) 2 (4.9)
Annually 12 (37.5) 20 (62.5) 20 (62.5) 7 (21.9) 5 (15.6)
Age (years) 0.934 0.456
20–25 13 (61.9) 8 (38.1) 16 (76.2) 4 (19.0) 1 (4.8)
26–35 62 (64.6) 34 (35.4) 83 (86.5) 7 (7.3) 6 (6.3)
36–45 39 (67.2) 19 (32.8) 52 (89.7) 3 (5.2) 3 (5.2)
45–55 12 (70.6) 5 (29.4) 13 (76.5) 3 (17.6) 1 (5.9)
Level of Hospital 0.047 0.284
Primary 118 (67.8) 56 (32.2) 149 (85.6) 14 (8.0) 11 (6.3)
Secondary 8 (44.4) 10 (55.6) 15 (83.3) 3 (16.7) 0 (0.0)
Type of prescriber 0.001 0.011
Doctor 37 (78.7) 10 (21.3) 46 (97.9) 1 (2.1) 0 (0.0)
Medical intern 3 (42.9) 4 (57.1) 5 (62.5) 3 (37.5) 0 (0.0)
Physician assistant 41 (73.2) 15 (26.8) 48 (85.7) 4 (7.1) 4 (7.1)
Physician assistant intern 23 (76.7) 7 (23.3) 25 (86.2) 3 (10.3) 1 (3.4)
Nurse 17 (47.2) 19 (52.8) 28 (77.8) 5 (13.9) 3 (8.3)
Others 5 (31.3) 11 (68.7) 12 (75.0) 1 (6.3) 3 (18.8)
Years of experience 0.167 0.172
≤3 years 63 (65.6) 33 (34.4) 75 (78.1) 11 (11.5) 10 (10.4)
>3–6 years 20 (58.8) 14 (41.2) 32 (94.1) 2 (5.9) 0 (0.0)
>6–10 years 22 (59.5) 15 (40.5) 34 (91.9) 2 (5.4) 1 (2.7)
>10 years 21 (84.0) 4 (16.0) 23 (92.0) 2 (8.0) 0 (0.0)
State of DTC 0.004 0.394
Functional 39 (83.0) 8 (17.0) 43 (91.5) 2 (4.3) 2 (4.3)
Nonfunctional 86 (59.7) 58 (40.3) 121 (83.4) 15 (10.3) 9 (6.2)

RUM = rational use of medicine; DTC = drugs and therapeutic committee; STG = standard treatment guidelines; BNF = British National Formulary

*p-value was determined using the chi-squared statistic.

δp-value was determined using Fisher’s exact test

Prescribers with access to reference sources were nearly three times more likely to transition from neutral to good perception (OR = 2.9; 95% CI: 1.3–6.6; p = 0.0095) (Table 3). However, compared to doctors, nurses (OR = 0.08, 95% CI: 0.01–0.61; p = 0.018), medical interns (OR = 0.04; 95% CI: 0.003–0.43, p = 0.008), and other prescribers, such as mental health nurses, disease control officers, and community health nurses (OR = 0.57; 95% CI: 0.01–0.56; p = 0.014), were less likely to improve from neutral to good perception.

Table 3. Factors influencing the odds of having good knowledge and transitioning from neutral to good perception of rational medicine use.

Characteristics Knowledge Perception
OR 95% CI p-value OR 95% CI δp-value
Using STG as a reference -
No 1
Yes 2.83 1.48–5.44 0.002 -* -
Using BNF as a reference -
No 1
Yes 2.81 1.48–5.31 0.001 - -
Frequency of drug bulletin update
Never updated 1
Monthly 2.64 0.98–7.07 0.054 0.87 0.25–3.08 0.834
Quarterly 1.22 0.57–2.63 0.510 1.43 0.41–4.98 0.570
Annually 0.33 0.13–0.81 0.015 0.21 0.07–0.62 0.005
Prescribing reference source accessible 0.009
No - - - 1
Yes 2.94 1.30–6.64
Functionality of DTC -
Nonfunctional 1 - -
Functional 3.28 1.43–7.54 0.005
Level of hospital -
Secondary 1 -
Primary 2.63 0.99–7.04 0.053 -
Category of prescribers
Doctor 1
Medical Intern 0.20 0.04–1.06 0.058 0.04 0.003–0.43 0.008
Physician Assistant 0.74 0.30–1.85 0.517 0.13 0.02–1.05 0.056
Physician Assistant Intern 0.89 0.30–2.66 0.832 0.14 0.02–1.34 0.089
Nurse Prescriber 0.24 0.09–0.64 0.004 0.08 0.01–0.64 0.018
Others 0.12 0.03–0.44 0.001 0.06 0.01–0.56 0.014
Using Medscape as a reference 0.673
No - - - 1
Yes 0.84 0.38–1.88

OR = odds ratio; CI = confidence interval; DTC = drugs and therapeutic committee; BNF = British National Formulary;

*Not statistically significant at the bivariate level. Boldface entries indicate statistically significant variables. “Others” include mental health nurses, disease control officers and community health nurses.

Binary logistic regression analysis.

δOrdinal logistic regression analysis.

Furthermore, prescribers whose drug bulletins were updated annually had significantly lower odds of transitioning from neutral to good perception compared to those whose bulletins were never updated (OR = 0.21, 95% CI: 0.07–0.62; p = 0.005).

Participants’ knowledge of rational use of medicines

The majority of participants (65.6%, n = 126) demonstrated a strong understanding of RUM. Notably, individuals working in primary hospitals exhibited significantly better knowledge compared to those in secondary (referral) hospitals (p = 0.047). Furthermore, participants who relied on the Standard Treatment Guideline (STG) and the British National Formulary (BNF) as their prescribing references showed superior knowledge of rational prescription practices, in contrast to those who used Medscape and the institutional drug bulletin (p = 0.001, p = 0.001, p = 0.057, and p = 0.174 respectively). The professional category of the prescriber (p = 0.001) and the frequency of updates of the hospital drug bulletin (p = 0.001) were also identified as significant factors influencing RUM knowledge. However, factors such as age, gender, employment status, and years of experience as a prescriber did not show significant relationships with prescriber knowledge.

In binary logistic regression analysis as depicted in Table 3, participants who utilized STG and BNF as prescription references had approximately three times the odds of possessing good prescription knowledge (OR = 2.83, 95%CI: 1.47–5.44; p = 0.002) and (OR = 2.81, 95%CI: 1.48–5.31; p = 0.001), respectively. Conversely, nurse prescribers (OR = 0.24; 95% CI: 0.09–0.64; p = 0.004), along with other healthcare professionals such as community health nurses, disease control officers, and mental health nurses (OR = 0.12; 95% CI: 0.03–0.44; p = 0.001), were less likely to demonstrate good RUM knowledge compared to doctors. Additionally, participants working in hospitals with functional DTCs were more likely to possess good prescribing knowledge (OR = 3.29; 95%CI: 1.43–7.54; p = 0.002) compared to those who did not have access to such resources.

Discussion

Overall, most participants demonstrated adequate knowledge and a positive perception of the concept of RUM. Specifically, 65.6% exhibited good knowledge in this area, while 85.4% held a positive perception. These figures surpass the rates found among postgraduate medical students in India, which were 61% for good knowledge and 51% for a positive perception [34]. Although the majority of participants in the present study possessed sound knowledge, it is essential for health policymakers to be concerned about those with insufficient knowledge (34.4%) because widespread adherence to RUM across all levels of healthcare is crucial for ensuring patient safety.

The profession of the prescriber plays a role in determining their level of understanding regarding RUM. Although there was no significant difference in knowledge between doctors and physician assistants, nurses and other prescribers exhibited lower odds of having a good knowledge compared to doctors. Additionally, a significantly smaller proportion of nurses, other prescribers and medical interns demonstrated a positive perception towards RUM and were less likely to move from neutral to good perception in comparison to doctors. This finding is consistent with prior research conducted among Ghanaian prescribers, specifically assessing knowledge of antimicrobial resistance, which revealed that doctors exhibited superior knowledge compared to Community Health Officers [35]. Similarly, a study conducted in Pakistan evaluating the knowledge, attitude, and practice of rational antibiotic use among health workers found that doctors attained higher knowledge scores than nurses [36]. These studies corroborate our findings and suggest a trend wherein doctors tend to demonstrate better RUM knowledge levels compared to nurses in similar contexts.

The discovery of RUM knowledge disparities among healthcare professionals, particularly concerning nurses and disease control officers raises significant concerns for patient safety within the health system. As lower-level health facilities rely on nurse prescribers, the potential for prescriptions falling short of required standards increases the risk of drug-related problems for patients [27]. Further research is imperative to delve into the underlying reasons behind these knowledge gaps among doctors and other healthcare professionals to address this concern. Crucially, it is paramount to ensure that nurse prescribers receive adequate training and mentoring to meet the requisite standards before independently prescribing medications [12, 30]. By investing in their professional development, healthcare systems can better equip these professionals to deliver safe and effective care, thereby safeguarding patient well-being and promoting optimal health outcomes. Furthermore, medical school curricula must enhance the training on RUM to equip newly trained doctors with a comprehensive understanding of this concept. This will ensure that they are well-prepared and up-to-date in their knowledge and application of RUM principles.

Participants who use STG and the BNF as their prescribing references exhibited better knowledge of rational prescribing, although their perception was not significantly affected. Those who rely on STG and BNF have more than twice the odds of good knowledge compared to those who do not use them. Additionally, having access to a prescriber’s preferred reference also increases their odds of transitioning from neutral to good perception by almost three times. These reference sources contain guidelines with evidence-based recommendations, making healthcare providers who regularly consult them more likely to possess knowledge in RUM [3, 37]. This finding aligns with a study in Saudi Arabia [3] which reported that access to the right prescription references improved prescriber knowledge and practice of RUM. The findings on prescription references, however, contradict a study conducted in the Netherlands, where authors reported that the source of prescription reference had no impact on rational prescribing [38]. However, the Netherlands study was conducted over forty years ago when internet access was not in existence to make reference sources freely available to prescribers. Therefore, this new finding in the current study may be attributed to the widely available and free prescribing reference sources that influence prescriber knowledge.

Furthermore, participants who work in hospitals that had access to institutional drug bulletins updated annually demonstrated lower knowledge levels and were less likely to transition from neutral to good perception compared to those with prescribers whose bulletins are never updated. This finding contradicts prevailing literature, which suggests that regular updates of the drug bulletin enhance prescriber knowledge for rational medicine use [12, 39]. Despite the bulletin’s role in disseminating crucial information on services, changes, new inclusions, and updates relevant to prescribing practices, including new evidence and clinical guidelines, the anticipated positive effect on prescriber knowledge and perception was not observed in our study. Further research is needed to understand the underlying factors contributing to this discrepancy, considering the potential influences such as variations in institutional practices and the quality of information in the bulletins.

The presence of a functional DTC in a participant’s hospital was found to significantly increase the odds of having good knowledge of RUM by more than three times. This finding aligns with other studies that reported improvements in rational prescribing and a reduction in medication errors when a hospital has a functional DTC [5, 12, 40, 41]. Therefore, it is crucial to empower hospitals to establish and adequately resource DTCs to effectively implement the RUM agenda and ensure patient safety.

Study limitations

The cross-sectional design of our study limits our ability to establish causal relationships, and the specific demographics of our sample may restrict the generalizability of our findings. Additionally, self-reported data introduce potential response bias and may not entirely reflect actual behaviours. Despite these limitations, our study provides valuable insights into the field of Rational Use of Medicines research.

Conclusion

The study revealed that most participants have a good knowledge and positive perception of RUM. However, nurses, community health nurses, mental health nurses, and disease control officers exhibited lower knowledge levels compared to doctors, indicating a need for targeted training programs within these groups. Additionally, the study found that relying on prescribing references was associated with higher levels of knowledge, and having access to preferred references improved the likelihood of having a positive perception. Moreover, the presence of functional DTCs in hospitals significantly influenced knowledge levels, emphasizing the importance of supporting hospitals in establishing and resourcing DTCs for safe medication use. Surprisingly, frequent updates of drug bulletins did not improve knowledge or perception, with prescribers whose bulletins were never updated showing better odds of having good knowledge and perception. Further research is needed to understand this discrepancy and its implications.

Supporting information

S1 Tool. Structured questionnaire used for data collection.

(DOCX)

pone.0308406.s001.docx (22.9KB, docx)
S1 Dataset. Dataset on prescriber knowledge and perception towards RUM.

(XLSX)

pone.0308406.s002.xlsx (32.6KB, xlsx)

Acknowledgments

The authors would like to express their gratitude to the Regional Director of Health, the management teams of the hospitals involved in the study, and the prescribers for their valuable and willing participation in the research.

Data Availability

All data sets associated with this manuscript have been added as a Supporting information.

Funding Statement

The author(s) received no specific funding for this work.

References

  • 1.Hogerzeil H V. Promoting rational prescribing: an international perspective. Br J Clin Pharmac 1995;39:1–6. doi: 10.1111/j.1365-2125.1995.tb04402.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.World Health Organization. The Role of Education in the Rational Use of Medicines. New Delhi: 2006.
  • 3.Baraka MA, Alboghdadly A, Alshawwa S, Elnour AA, Alsultan H, Alsalman T, et al. Perspectives of healthcare professionals regarding factors associated with antimicrobial resistance (Amr) and their consequences: A cross sectional study in eastern province of saudi arabia. Antibiotics 2021;10. doi: 10.3390/antibiotics10070878 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Ayani I, Aguirre C, Gutierrez G, Madariaga A. A cost analysis of suspected adverse drug reaction in a hospital emergency ward. Pharmacoepidemiol Drug Saf, Pp 1999:529–34. [DOI] [PubMed]
  • 5.Ofori-Asenso R, Agyeman A. Irrational Use of Medicines—A Summary of Key Concepts. Pharmacy 2016;4:35. doi: 10.3390/pharmacy4040035 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Maxwell SRJ. Rational prescribing: the principles of drug selection. Clinical Medicine 2016;16:459. doi: 10.7861/clinmedicine.16-5-459 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Pollock M, Bazaldua O V, Dobbie AE. Appropriate prescribing of medications: an eight-step approach. Am Fam Physician 2007;75:231–6. [PubMed] [Google Scholar]
  • 8.Maxwell S. Rational prescribing: the principles of drug selection. Clinical Medicine 2009;9:481. doi: 10.7861/clinmedicine.9-5-481 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Chauhan I, Yasir M, Kumari M, Verma M. The pursuit of rational drug use: understanding factors and interventions. Pharmaspire 2018;10:44–8. [Google Scholar]
  • 10.Bennett F, Ferner R, Sofat R. Overprescribing and rational therapeutics: Barriers to change and opportunities to improve. Br J Clin Pharmacol 2021;87:34–8. doi: 10.1111/bcp.14291 [DOI] [PubMed] [Google Scholar]
  • 11.Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther 2001;23:1296–310. doi: 10.1016/s0149-2918(01)80109-0 [DOI] [PubMed] [Google Scholar]
  • 12.Laing R, Hogerzeil H, Ross-Degnan D. Ten recommendations to improve use of medicines in developing countries. Health Policy Plan 2001;16:13–20. doi: 10.1093/heapol/16.1.13 [DOI] [PubMed] [Google Scholar]
  • 13.Mekonnen B, Ayalew M, Tegegn A. Rational Drug Use Evaluation Based on World Health Organization Core Drug Use Indicators in Ethiopia: A Systematic Review 2021. [DOI] [PMC free article] [PubMed]
  • 14.Lima MG, Álvares J, Guerra Junior AA, Costa EA, Guibu IA, Soeiro OM, et al. Indicators related to the rational use of medicines and its associated factors. Rev Saude Publica 2017;51:1s–8s. doi: 10.11606/S1518-8787.2017051007137 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Afriyie D, Tetteh R. A description of the pattern of rational drug use in Ghana Police Hospital. International Journal of Pharmacy and Pharmacology 2014;3:143–8. [Google Scholar]
  • 16.Mahmood A, Elnour AA, Ali AAA, Hassan NAGM, Shehab A, Bhagavathula AS. Evaluation of rational use of medicines (RUM) in four government hospitals in UAE. Saudi Pharmaceutical Journal 2016;24:189–96. doi: 10.1016/j.jsps.2015.03.003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Jafar TH, Jessani S, Jafary FH, Ishaq M, Orkazai R, Orkazai S, et al. General practitioners’ approach to hypertension in urban Pakistan: disturbing trends in practice. Circulation 2005;111:1278–83. doi: 10.1161/01.CIR.0000157698.78949.D7 [DOI] [PubMed] [Google Scholar]
  • 18.Krause G, Borchert M, Benzler J, Heinmüller R, Kaba I, Savadogo M, et al. Rationality of drug prescriptions in rural health centres in Burkina Faso. Health Policy Plan 1999;14:291–8. doi: 10.1093/heapol/14.3.291 [DOI] [PubMed] [Google Scholar]
  • 19.Illing J, Morrow G, Kergon C, Burford B, Spencer J, Peile E, et al. How prepared are medical graduates to begin practice? A comparison of three diverse UK medical schools. GMC; 2008.
  • 20.Chaudhari VL, Mali SN, Dawari A V, Nishandar TB. Awareness about rational use of medicines among fresh bachelor of medicine and bachelor of surgery graduates. J Educ Health Promot 2017;6. doi: 10.4103/jehp.jehp_59_17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Jackson SHD, Mangoni AA, Batty GM. Optimization of drug prescribing. Br J Clin Pharmacol 2004;57:231–6. doi: 10.1046/j.1365-2125.2003.02018.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Garcia-Vello P, Brobbey F, Gonzalez-Zorn B, Saba CKS. A cross-sectional study on antibiotic prescription in a teaching hospital in Ghana. Pan African Medical Journal 2020;35. doi: 10.11604/pamj.2020.35.12.18324 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Okeke IN, Laxminarayan R, Bhutta ZA, Duse AG, Jenkins P, O’Brien TF, et al. Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect Dis 2005;5:481–93. doi: 10.1016/S1473-3099(05)70189-4 [DOI] [PubMed] [Google Scholar]
  • 24.Camcioglu Y, Alhan E, Salman N, Somer A, Hatipog N, Celik U. Inappropriate antimicrobial use in Turkish pediatric hospitals: A multicenter point prevalence survey 2010. [DOI] [PubMed]
  • 25.Classen DC, Jaser L, Budnitz DS. Adverse Drug Events Among Hospitalized Medicare Patients: Epidemiology and National Estimates from a New Approach to Surveillance. The Joint Commission Journal on Quality and Patient Safety 2010;36:12–AP9. doi: 10.1016/s1553-7250(10)36003-x [DOI] [PubMed] [Google Scholar]
  • 26.Budnitz D, Shehab N, Kegler S, Richard C. Medication use leading to emergency department visits for adverse drug events in older adults. Ann Intern Med, Volume 147; 2007, p. 755–65. doi: 10.7326/0003-4819-147-11-200712040-00006 [DOI] [PubMed] [Google Scholar]
  • 27.Hogerzeil H V., Bimo, Ross-Degnan D, Laing RO, Ofori-Adjei D, Santoso B, et al. Field tests for rational drug use in twelve developing countries. The Lancet 1993;342:1408–10. doi: 10.1016/0140-6736(93)92760-q [DOI] [PubMed] [Google Scholar]
  • 28.Baiardini I, Guerra L, Pasquali M, Bonadonna P, Passalaqua G, Canonica GW. Quality of life in patients with adverse reactions to drugs: Preliminary results from a new questionnaire. Journal of Allergy and Clinical Immunology 2004;113:S70. doi: 10.1016/J.JACI.2003.12.223 [DOI] [Google Scholar]
  • 29.Djochie R, Owusu-Donkor R, d’Almeida E, Fordjour F, Gyamfi Akwah F, Kyeremateng E, et al. Evaluation of rational medicine prescribing: A cross-sectional study of public hospitals in the Ashanti Region of Ghana. Res Sq 2023. doi: 10.21203/rs.3.rs-3059557/v1 [DOI] [Google Scholar]
  • 30.de Vries TPGM, Henning RH, Hogerzeil H V., Bapna JS, Bero L, Kafle KK, et al. Impact of a short course in pharmacotherapy for undergraduate medical students: an international randomised controlled study. The Lancet 1995;346:1454–7. doi: 10.1016/S0140-6736(95)92472-8 [DOI] [PubMed] [Google Scholar]
  • 31.Ofori-Asenso R, Brhlikova P, Pollock AM. Prescribing indicators at primary health care centers within the WHO African region: A systematic analysis (1995–2015). BMC Public Health 2016;16. doi: 10.1186/s12889-016-3428-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Majumder MAA, Rahman S, Cohall D, Bharatha A, Singh K, Haque M, et al. Antimicrobial stewardship: Fighting antimicrobial resistance and protecting global public health. Infect Drug Resist 2020;13:4713–38. doi: 10.2147/IDR.S290835 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Kaki R, Elligsen M, Walker S, Simor A, Palmay L, Daneman N. Impact of antimicrobial stewardship in critical care: A systematic review. Journal of Antimicrobial Chemotherapy 2011;66:1223–30. doi: 10.1093/jac/dkr137 [DOI] [PubMed] [Google Scholar]
  • 34.Malhotra N, Shivaswamy MS. Knowledge, attitude, and practices of rational use of medicines among the postgraduate residents of a tertiary care teaching hospital in North Karnataka: A facility-based cross-sectional study 2023.
  • 35.Asante KP, Boamah EA, Abdulai MA, Buabeng KO, Mahama E, Dzabeng F, et al. Knowledge of antibiotic resistance and antibiotic prescription practices among prescribers in the Brong Ahafo Region of Ghana; a cross-sectional study. BMC Health Serv Res 2017;17:422. doi: 10.1186/s12913-017-2365-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Afzal S, Khan FU, Aqeel MT, Ullah M, Bajwa M, Akhtar M, et al. Impact of a pharmacist-led educational intervention on knowledge, attitude, and practice toward the rational use of antibiotics among healthcare workers in a secondary care hospital in Punjab, Pakistan. Front Pharmacol 2024;14:1327576. doi: 10.3389/fphar.2023.1327576 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Md Rezal R, Hassali M, Alrasheedy A, Saleem F, Md Yusof F, Godman B. Physicians’ knowledge, perceptions and behaviour towards antibiotic prescribing: a systematic review of the literature. Expert Rev Anti Infect Ther 2015;13:665–80. doi: 10.1586/14787210.2015.1025057 [DOI] [PubMed] [Google Scholar]
  • 38.Haayer F. Rational prescribing and sources of information. Soc Sci Med 1982;16:2017–23. doi: 10.1016/0277-9536(82)90158-7 [DOI] [PubMed] [Google Scholar]
  • 39.Persson EL, Miller KS, Nieman JA, Sgourakis AP, Akkerman SR. Formulary evaluation using a class review approach: experience and results from an academic medical center. Pharmacy and Therapeutics 2013;38:213. [PMC free article] [PubMed] [Google Scholar]
  • 40.Yang J, Zheng L, Guan YY, Lv YT. Drug and therapeutics committee interventions in managing irrational drug use and antimicrobial stewardship in China. Front Pharmacol 2022;13. doi: 10.3389/fphar.2022.829408 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.WHO. How to investigate rational drug use in health facilities. Geneva: 1993.

Decision Letter 0

Ashish Kakkar

8 Apr 2024

PONE-D-23-33862Assessment of knowledge and perception of prescribers towards rational medicine use in the Ashanti Region of GhanaPLOS ONE

Dear Dr. Djochie,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by May 23 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

A Kakkar

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Additional Editor Comments:

This paper evaluates the understanding and attitudes of prescribers in public hospitals in Ghana towards the rational use of medicines, a crucial aspect in mitigating treatment failures, reducing healthcare costs, and minimising drug toxicities and interactions.

Comments:

1. It will be useful to describe in the methods section as to who all are considered as prescribers in Ghana. There is a category designated as 'others' also.

2. A copy of questionnaire used in this study is needed. The authors mention that each correctly answered question was assigned one point. The questionnaire will help the readers in understanding what is meant by 'good knowledge' and positive perception'. What is meant by correct answers???

3. Similarly it is mentioned that "participants who achieved a score of 70% or higher were classified as having a good level of rational prescribing knowledge

or perception, respectively." since there were only 5 questions for perception (text mentions six(Q26-30)????) how was 70% determined. The methodology regarding rounding off etc needs to be mentioned. Also were only 5 questions considered enough for gauging perception of prescribers?

4. There is a term 'reference source available' used. What is meant by this? This needs to be described in text.

5. Do all healthcare facilities included in this study have their own STGs and drug bulletins? Any previous studies on availability of these in Ghana can be cited in the text.

6.p-value mentioned in line 227 is not in alignment with the values in table. The positive perception mentioned is not significant.

7. Interestingly, with respect to frequency of drug bulletin updates, odds of good knowledge and positive perception are lower in participants where there is an annual update as compared to when they are never updated!

8. Discussion: statement "This finding contradicts a systematic review which indicates that medications prescribed by nurse prescribers are as effective and lead to positive patient outcomes, similar to physician prescribing" is difficult to correlate with findings of this study that looks at prescriber knowledge and attitudes.

9. Similarly: "This finding aligns with a study conducted in Turkey, which revealed that nurses with eleven or more years of experience were less prone to medication errors" seems to link perception with medication errors.

10. Limitations of the study such as cross sectional design, limited generalisability, self reported data, social desirability bias etc. need to be included in the discussion. Acknowledging these limitations is important for contextualising study's findings within broader landscape of research on RUM.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The study addresses an important issue of rational use of medicines by assessing the knowledge and perception of the prescribers of a region of Ghana. The study design and analysis seem appropriate. However since the questionnaire is not accessible, it is difficult to assess the appropriateness of the questions to test knowledge and perception. Moreover the details about who were involved in preparation of the tool and what were the sources referred to prepare the same is not mentioned and also who validated the questionnaire is not known.

Reviewer #2: It is a well written manuscript on and such research is relevant to highlight importance of rationally use of medicines. Please ensure data is available through a supplementary file, I could not see it attached as supplementary material.

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Ratinder Jhaj

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Oct 31;19(10):e0308406. doi: 10.1371/journal.pone.0308406.r002

Author response to Decision Letter 0


30 Apr 2024

We appreciate the opportunity to respond to the comments provided by the academic editor and reviewers regarding our manuscript titled "Assessment of Knowledge and Perception of Prescribers towards Rational Medicine Use in the Ashanti Region of Ghana." We have carefully considered each point raised and have made revisions accordingly. Below, we provide point-by-point responses to the concerns raised:

1. We have duly noted the diverse range of healthcare professionals involved in the medication prescribing process in Ghana, as outlined in the methods section on page 6. We acknowledge the inclusion of mental health nurses, disease control officers, and community health nurses categorized as “Others” in the data analysis.

2. A copy of the study questionnaire, including the bolded correct answers to the knowledge questions, has been uploaded as per the reviewer's suggestion.

3. The threshold score for determining good knowledge and perception has been clarified to be 70%, with corrections made in the text regarding the number of items used to assess perception and knowledge. Additionally, it has been indicated in the methods section that knowledge scores, when converted to percentages, have been rounded to one decimal place using standard rounding rules. The perception score analysis has been redone using ordinal logistic regression. This has also been indicated in the method section.

4. We have changed the term "reference source available" to “reference source accessible” under the results subsection. This clarification aims to facilitate better understanding and ease of referencing when necessary.

5. The existence of a national Standard Treatment Guideline (STG) developed by the Ministry of Health of Ghana, along with the process of formulary list development by individual hospitals, has been appropriately addressed. We acknowledge the limitation of not verifying respondents' answers regarding the availability of STG in their hospitals and this has been noted in the study limitations statement.

6. The statement regarding the association between functional Drug and Therapeutic Committees (DTCs) and RUM knowledge has been corrected as per the reviewer's suggestion.

7. The discussion section has been revised to address the unexpected finding regarding the relationship between updates to the drug bulletin and prescriber knowledge. We acknowledge the need for further research to understand the underlying factors contributing to this discrepancy.

8. We have revised the discussion to provide context from prior research on knowledge levels among Ghanaian prescribers, particularly comparing doctors and Community Health Officers, as well as findings from similar studies conducted in Pakistan.

9. The discussion has been redone after the ordinal regression analysis aligned with our study's results.

10. A study limitation statement has been included before the conclusion, highlighting the cross-sectional design's limitations and potential biases introduced by self-reported data.

We believe these revisions have strengthened the manuscript and addressed the concerns raised by the academic editor and reviewers. We thank the editorial team for their valuable feedback and consideration of our submission.

Attachment

Submitted filename: Response to Reviewers.docx

pone.0308406.s003.docx (16.6KB, docx)

Decision Letter 1

Obed Kwabena Offe Amponsah

19 Jul 2024

PONE-D-23-33862R1Assessment of knowledge and perception of prescribers towards rational medicine use in the Ashanti Region of GhanaPLOS ONE

Dear Dr. Djochie,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Kindly see the comments from reviewer 2 

"In Discussion: In the first sentence it is better to avoid adjectives like 'solid' for comprehension.

Moreover, knowledge and not comprehension was assessed, so the term 'knowldge' needs to be used consistently.

Similarly in Conclusion the term 'understanding' may be replaced with 'knowledge' " 

As this is a very minor revision request, kindly submit the correction as soon as possible to allow prompt processing of the article for publication.​

Please submit your revised manuscript by Sep 02 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Obed Kwabena Offe Amponsah, PharmD, Ph.D.

Academic Editor

PLOS ONE

Journal Requirements:

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The authors have addressed all the queries point wise and the explanations provided are satisfactory

Reviewer #2: Almost all reviewer comments have been addressed. Only one samll correction in Discussion and Conclusion.

In Discussion: In the first sentence it is better to avoid adjectives like 'solid' for comprehension.

Moreover, knowledge and not comprehension was assessed, so the term 'knowldge' needs to be used consistently.

Similarly in Conlusion the term'understanding may be replaced with 'knowledge'

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Ratinder Jhaj

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2024 Oct 31;19(10):e0308406. doi: 10.1371/journal.pone.0308406.r004

Author response to Decision Letter 1


20 Jul 2024

1. In the Discussion section, the first sentence has been rewritten to remove the phrase “solid comprehension” and now reads: "Overall, most participants demonstrated adequate knowledge and a positive perception of the concept of RUM."

2. The term "knowledge" has been used consistently throughout the discussion, replacing "comprehension" and other similar words to avoid ambiguity.

3. In the Conclusion, the term “understanding” has been replaced with “knowledge” as suggested by the reviewer.

4. The references list has been checked to ensure it is complete.

Attachment

Submitted filename: Response to Reviewers.docx

pone.0308406.s004.docx (15.3KB, docx)

Decision Letter 2

Obed Kwabena Offe Amponsah

24 Jul 2024

Assessment of knowledge and perception of prescribers towards rational medicine use in the Ashanti Region of Ghana

PONE-D-23-33862R2

Dear Dr. Djochie,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Obed Kwabena Offe Amponsah, PharmD, Ph.D.

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Thank you for your prompt action on the prior revision request and all the best in future manuscripts.

Reviewers' comments:

Acceptance letter

Obed Kwabena Offe Amponsah

29 Jul 2024

PONE-D-23-33862R2

PLOS ONE

Dear Dr. Djochie,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Obed Kwabena Offe Amponsah

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Tool. Structured questionnaire used for data collection.

    (DOCX)

    pone.0308406.s001.docx (22.9KB, docx)
    S1 Dataset. Dataset on prescriber knowledge and perception towards RUM.

    (XLSX)

    pone.0308406.s002.xlsx (32.6KB, xlsx)
    Attachment

    Submitted filename: Response to Reviewers.docx

    pone.0308406.s003.docx (16.6KB, docx)
    Attachment

    Submitted filename: Response to Reviewers.docx

    pone.0308406.s004.docx (15.3KB, docx)

    Data Availability Statement

    All data sets associated with this manuscript have been added as a Supporting information.


    Articles from PLOS ONE are provided here courtesy of PLOS

    RESOURCES